There is 1 paper on GSTM1NULLGENOTYPE in aging research: 1 observational study in people.
1 paper studies it3 findings
See all 1 papers on GSTM1NULLGENOTYPE
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“There was a significant difference in the GSTM1 null genotype frequency between the patients and controls (0.59 vs. 0.38, p ≤ 0.000)”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Trakia University
- Humans1
Effects
2Glutathione
downin humans1
1 study
Glutathione
downin humans1
GSTM1NULLGENOTYPE is linked with lower glutathione in controls (15.39 ng/mL vs. 5.53 ng/mL, p = 0.002).
“The total glutathione level in GSTM1 non-null controls was higher compared to the null genotype (15.39 ng/mL vs. 5.53 ng/mL, p = 0.002).”
Humansin controls
Current issues in molecular biology
Telomere length
downin humans1
1 study
Telomere length
downin humans1
GSTM1NULLGENOTYPE is linked with lower telomere length in COPD patients (15,720 bp vs. 22,442 bp, p = 0.008).
“COPD patients carrying the GSTM1 null genotype had shorter telomeres compared to those carrying the non-null genotype (15,720 bp vs. 22,442 bp, p = 0.008)”
Humansin COPD patients
Current issues in molecular biology
Associations
1Chronic obstructive pulmonary disease
upin humans1
1 study
Chronic obstructive pulmonary disease
upin humans1
GSTM1NULLGENOTYPE is linked with a higher risk of chronic obstructive pulmonary disease in humans (patients vs controls) (0.59 vs. 0.38, p ≤ 0.000).
“There was a significant difference in the GSTM1 null genotype frequency between the patients and controls (0.59 vs. 0.38, p ≤ 0.000)”
Humanspatients vs controls
Current issues in molecular biology